Consumption of antidepressants in Italy: Recent trends and their significance for public health

Psychiatric Services

Volumn 65, Issue 10, 2014, Pages 1226-1231

  Gualano, Maria Rosaria ^a   Bert, Fabrizio ^a   Mannocci, Alice ^b   La Torre, Giuseppe ^b   Zeppegno, Patrizia ^c   Siliquini, Roberta ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; DRUG COST; DRUG DATABASE; DRUG UTILIZATION; FEMALE; HUMAN; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; SOCIAL STIGMA; SOCIOECONOMICS; TIME SERIES ANALYSIS; TREND STUDY; AGED; DEPRESSIVE DISORDER; FACTUAL DATABASE; MIDDLE AGED; PUBLIC HEALTH; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; DATABASES, FACTUAL; DEPRESSIVE DISORDER; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PUBLIC HEALTH;

EID: 84907653054     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201300510     Document Type: Article

References (38)

1. Depression. Fact sheet no 369. Geneva, World Health Organization, 2012. Available at www.who.int/mediacentre/factsheets/fs369/en. Accessed April 15, 2013
2. Lozano R, Naghavi M, Foreman K, et al: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095-2128, 2012
3. Murray CJ, Lopez AD: The Global Burden of Disease. Cambridge, Mass, Harvard School of Public Health, 1996
4. Siliquini R, Bert F, Alonso F, et al: Correlation between driving-related skill and alcohol use in young adults from six European countries: the TEN-D by Night Project. BMC Public Health 11:526--537, 2011
5. Mental Health in OECD Countries. Paris, OECD, 2008
6. de Girolamo G, Polidori G, Morosini P, et al: Prevalence of common mental disorders in Italy: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD). Social Psychiatry and Psychiatric Epidemiology 41:853-861, 2006
7. Arias LH, Lobato CT, Ortega S, et al: Trends in the consumption of antidepressants in Castilla y León (Spain): association between suicide rates and antidepressant drug consumption. Pharmacoepidemiology and Drug Safety 19:895-900, 2010
8. Olfson M, Marcus SC: National patterns in antidepressant medication treatment. Archives of General Psychiatry 66:848-856, 2009
9. Exeter D, Robinson E, Wheeler A: Antidepressant dispensing trends in New Zealand between 2004 and 2007. Australian and New Zealand Journal of Psychiatry 43:1131-1140, 2009
10. Deambrosis P, Chinellato A, Terrazzani G, et al: Antidepressant drug prescribing patterns to outpatients of an Italian local health authority during the years 1998 to 2008. Journal of Clinical Psychopharmacology 30:212-215, 2010
11. Verdoux H, Tournier M, Bégaud B: Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatrica Scandinavica 121:4-10, 2010
12. Impact of Economic Crisis on Mental Health. Geneva, World Health Organization, 2011. Available at www.euro.who.int/--data/assets/pdf-file/0008/134999/e94837.pdf
13. Olié JP, Elomari F, Spadone C, et al: Antidepressants consumption in the global population in France [in French]. L'Encéphale 28:411-417, 2002
14. Rapporto OsservaSalute [Italian Observatory on Healthcare Report 2010]. Milan, Osservasalute, 2011. Available at www.osservasalute.it
15. Ciuna A, Andretta M, Corbari L, et al: Are we going to increase the use of antidepressants up to that of benzodiazepines? European Journal of Clinical Pharmacology 60:629-634, 2004
16. Barbui C, Campomori A, D'Avanzo B, et al: Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates. Social Psychiatry and Psychiatric Epidemiology 34:152-156, 1999
17. Guaiana G, Andretta M, Corbari L, et al: Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000. Journal of Clinical Psychiatry 66:750-755, 2005
18. Torre E, Zeppegno P, Usai C, et al: Suicide in Verbano-Cusio-Ossola province: decade 1990-2000 [in Italian]. Epidemiologia e Psichiatria Sociale 11:277-283, 2002
19. osMED Report 2009. Rome, Italian Medicines Agency, 2009. Available at www.agenziafarmaco.gov.it/it/content/luso-dei-farmaci-italia-rapporto-osmed-2009
20. Guidelines for ATC Classification and DDD Assignment. Oslo, Norway, World Health Organization Collaborating Centre for Drug Statistics Methodology, 2003. Available at www.whocc.no/atc-ddd-publications/guidelines
21. Kavaliauskiene L, Pečiu¯ra R, Adomaitiene V: Trends in depression diagnosis and consumption of antidepressants in Lithuania in 2004-2009. Acta Medica Lituanica 18:17-22, 2011
22. Kim HJ, Fay MP, Feuer EJ, et al: Permutation tests for joinpoint regression with applications to cancer rates. Statistics in Medicine 19:335-351, 2000
23. Torre GL, Gualano MR, Semyonov L, et al: Hepatitis C virus infections trends in Italy, 1996-2006. Hepatitis Monthly 11:895-900, 2011
24. osMED Report 2011. Rome, Italian Medicines Agency, 2009. Available at www.agenziafarmaco.gov.it/it/content/luso-deifarmaci-italia-rapporto-osmed-gennaio-settembre-2011
25. Kelly CB, Ansari T, Rafferty T, et al: Antidepressant prescribing and suicide rate in Northern Ireland. European Psychiatry 18:325-328, 2003
26. Reseland S, Bray I, Gunnell D: Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries. British Journal of Psychiatry 188:354-358, 2006
27. Helgason T, Tómasson H, Zoega T: Antidepressants and public health in Iceland: time series analysis of national data. British Journal of Psychiatry 184:157-162, 2004
28. Fürst J, Kocmur M: Use of psychiatric drugs in Slovenia in comparison to Scandinavian countries. Pharmacoepidemiology and Drug Safety 12:399-403, 2003
29. Depression in Primary Care: Treatment of Major Depression. Pub no 93-0551. Rockville, Md, US Department of Health and Human Services; Agency for Health Care Policy and Research, 1993
30. Spitzer RL, Williams JB, Kroenke K, et al: Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1,000 study. JAMA 272:1749-1756, 1994
31. Gender and Women's Mental Health. Geneva, World Health Organization. Available at www.who.int/mental-health/prevention/genderwomen/en. Accessed October 1, 2013
32. Connolly KR, Thase ME: Emerging drugs for major depressive disorder. Expert Opinion on Emerging Drugs 17:105-126, 2012
33. McManus P, Mant A, Mitchell PB, et al: Recent trends in the use of antidepressant drugs in Australia, 1990-1998. Medical Journal of Australia 173:458-461, 2000
34. Pizzi C, Rutjes AW, Costa GM, et al: Meta-analysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease. American Journal of Cardiology 107:972-979, 2011
35. Ilyas S, Moncrieff J: Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. British Journal of Psychiatry 200:393-398, 2012
36. Meyerhoefer CD, Zukevas SH: The shape of demand: what does it tell us about direct-to-consumer marketing of antidepressants? Advances in Economic Analysis and Policy 8:1805-1805, 2008
37. Jané-Llopis E, Hosman C, Jenkins R, et al: Predictors of efficacy in depression prevention programmes: meta-analysis. British Journal of Psychiatry 183:384-397, 2003
38. Verdoux H, Cortaredona S, Dumesnil H, et al: Psychotherapy for depression in primary care: a panel survey of general practitioners' opinion and prescribing practice. Social Psychiatry and Psychiatric Epidemiology 49:59-68, 2013